1. Home
  2. SAMG vs SLGL Comparison

SAMG vs SLGL Comparison

Compare SAMG & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Silvercrest Asset Management Group Inc.

SAMG

Silvercrest Asset Management Group Inc.

HOLD

Current Price

$15.75

Market Cap

126.6M

Sector

Finance

ML Signal

HOLD

Logo Sol-Gel Technologies Ltd.

SLGL

Sol-Gel Technologies Ltd.

HOLD

Current Price

$61.75

Market Cap

117.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SAMG
SLGL
Founded
2002
1997
Country
United States
Israel
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
126.6M
117.8M
IPO Year
2013
2018

Fundamental Metrics

Financial Performance
Metric
SAMG
SLGL
Price
$15.75
$61.75
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$110.00
AVG Volume (30 Days)
39.6K
22.1K
Earning Date
03-05-2026
11-20-2025
Dividend Yield
5.42%
N/A
EPS Growth
N/A
N/A
EPS
0.72
N/A
Revenue
$125,322,000.00
$18,970,000.00
Revenue This Year
$3.44
$122.71
Revenue Next Year
$9.39
N/A
P/E Ratio
$21.54
N/A
Revenue Growth
4.23
62.04
52 Week Low
$13.23
$4.02
52 Week High
$19.04
$74.25

Technical Indicators

Market Signals
Indicator
SAMG
SLGL
Relative Strength Index (RSI) 62.74 64.28
Support Level $15.26 $60.20
Resistance Level $16.16 $71.99
Average True Range (ATR) 0.38 5.56
MACD -0.02 1.48
Stochastic Oscillator 61.12 64.61

Price Performance

Historical Comparison
SAMG
SLGL

About SAMG Silvercrest Asset Management Group Inc.

Silvercrest Asset Management Group Inc is a wealth management firm focused on providing financial advisory and related family office services to ultra-high net-worth individuals and institutional investors. It advises clients on traditional investment strategies focused on equities, fixed income and cash as well as non-traditional investment strategies including hedge funds, private equity funds, real estate and commodities. It also provides clients with family office services and related administrative services, which include financial planning, tax planning and preparation, partnership accounting and fund administration, and consolidated wealth reporting. The company derives revenues principally from assets under management.

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.

Share on Social Networks: